AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

INSULINE ASPARTE

7 registrations across 3 African markets— 7 active

Markets with INSULINE ASPARTE

Recent registrations

Brand / ProductMarketHolderStatusExpires
NOVORAPID FLEXPEN 100U/ML SOLUTION INJECTABLE SC/IV STYLO PRE-REMPLI FLACON DE 3ML🇨🇮Côte d'IvoireNOVO NORDISK A/SactiveJan 2028
NOVOMIX 100U/ML SUSPENSION INJECTABLE SC STYLO PRE-REMPLI FLACON DE 3ML🇨🇮Côte d'IvoireNOVO NORDISK A/SactiveJan 2028
NOVOMIX® 30 FLEXPEN® 100 U/ML SI SC STY PR BTE (5 X 3ML)
suspension injectable, boîte
🇲🇬MadagascarNOVO NORDISK A/Sactive
NOVORAPID® FLEXPEN® 100 U/ML SI SC/IV STY PR BTE (5 X 3ML)
suspension injectable, boîte
🇲🇬MadagascarNOVO NORDISK A/Sactive
NOVOMIX 30
solution injectable / 100 ui / ml
🇸🇳SenegalNOVO NORDISK ASactive
NOVOMIX® 30 FLEXPEN® 100 U/ML SI SC STY PR BTE (5 X 3ML)
suspension injectable, boîte
🇲🇬MadagascarNOVO NORDISK A/Sactive
NOVORAPID® FLEXPEN® 100 U/ML SI SC/IV STY PR BTE (5 X 3ML)
suspension injectable, boîte
🇲🇬MadagascarNOVO NORDISK A/Sactive

INSULINE ASPARTE in Africa — Regulatory Overview

INSULINE ASPARTE is registered across 3 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Madagascar, Côte d'Ivoire, Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 7 registrations, 7 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.